Serveur d'exploration sur le peuplier

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Populus balsamifera Extract and Its Active Component Salicortin Reduce Obesity and Attenuate Insulin Resistance in a Diet-Induced Obese Mouse Model.

Identifieur interne : 002537 ( Main/Exploration ); précédent : 002536; suivant : 002538

Populus balsamifera Extract and Its Active Component Salicortin Reduce Obesity and Attenuate Insulin Resistance in a Diet-Induced Obese Mouse Model.

Auteurs : Despina Harbilas [Canada] ; Diane Vallerand ; Antoine Brault ; Ammar Saleem ; John T. Arnason ; Lina Musallam ; Pierre S. Haddad

Source :

RBID : pubmed:23781256

Abstract

Populus balsamifera L. (BP) is a medicinal plant stemming from the traditional pharmacopoeia of the Cree of Eeyou Istchee (CEI-Northern Quebec). In vitro screening studies revealed that it strongly inhibited adipogenesis in 3T3-L1 adipocytes, suggesting potential antiobesity activity. Salicortin was identified, through bioassay-guided fractionation, as the active component responsible for BP's activity. The present study aimed to assess the potential of BP and salicortin at reducing obesity and features of the metabolic syndrome, in diet-induced obese C57Bl/6 mice. Mice were subjected to high fat diet (HFD) for sixteen weeks, with BP (125 or 250 mg/kg) or salicortin (12.5 mg/kg) introduced in the HFD for the last eight of the sixteen weeks. BP and salicortin effectively reduced whole body and retroperitoneal fat pad weights, as well as hepatic triglyceride accumulation. Glycemia, insulinemia, leptin, and adiponectin levels were also improved. This was accompanied by a small yet significant reduction in food intake in animals treated with BP. BP and salicortin (slightly) also modulated key components in signaling pathways involved with glucose regulation and lipid oxidation in the liver, muscle, and adipose tissue. These results confirm the validity of the CEI pharmacopoeia as alternative and complementary antiobesity and antidiabetic therapies.

DOI: 10.1155/2013/172537
PubMed: 23781256
PubMed Central: PMC3678421


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Populus balsamifera Extract and Its Active Component Salicortin Reduce Obesity and Attenuate Insulin Resistance in a Diet-Induced Obese Mouse Model.</title>
<author>
<name sortKey="Harbilas, Despina" sort="Harbilas, Despina" uniqKey="Harbilas D" first="Despina" last="Harbilas">Despina Harbilas</name>
<affiliation wicri:level="1">
<nlm:affiliation>Canadian Institutes of Health Research (CIHR) Team in Aboriginal Antidiabetic Medicines, Université de Montréal, P.O. Box 6128, Downtown Station, Montréal, QC, Canada H3C 3J7 ; Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Downtown Station, Montréal, QC, Canada H3C 3J7 ; Institute of Nutrition and Functional Foods, Université Laval, Quebec City, QC, Canada G1V 0A6 ; Montreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada H1W 4A4.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Canadian Institutes of Health Research (CIHR) Team in Aboriginal Antidiabetic Medicines, Université de Montréal, P.O. Box 6128, Downtown Station, Montréal, QC, Canada H3C 3J7 ; Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Downtown Station, Montréal, QC, Canada H3C 3J7 ; Institute of Nutrition and Functional Foods, Université Laval, Quebec City, QC, Canada G1V 0A6 ; Montreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC</wicri:regionArea>
<wicri:noRegion>QC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Vallerand, Diane" sort="Vallerand, Diane" uniqKey="Vallerand D" first="Diane" last="Vallerand">Diane Vallerand</name>
</author>
<author>
<name sortKey="Brault, Antoine" sort="Brault, Antoine" uniqKey="Brault A" first="Antoine" last="Brault">Antoine Brault</name>
</author>
<author>
<name sortKey="Saleem, Ammar" sort="Saleem, Ammar" uniqKey="Saleem A" first="Ammar" last="Saleem">Ammar Saleem</name>
</author>
<author>
<name sortKey="Arnason, John T" sort="Arnason, John T" uniqKey="Arnason J" first="John T" last="Arnason">John T. Arnason</name>
</author>
<author>
<name sortKey="Musallam, Lina" sort="Musallam, Lina" uniqKey="Musallam L" first="Lina" last="Musallam">Lina Musallam</name>
</author>
<author>
<name sortKey="Haddad, Pierre S" sort="Haddad, Pierre S" uniqKey="Haddad P" first="Pierre S" last="Haddad">Pierre S. Haddad</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2013">2013</date>
<idno type="RBID">pubmed:23781256</idno>
<idno type="pmid">23781256</idno>
<idno type="doi">10.1155/2013/172537</idno>
<idno type="pmc">PMC3678421</idno>
<idno type="wicri:Area/Main/Corpus">002559</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">002559</idno>
<idno type="wicri:Area/Main/Curation">002559</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">002559</idno>
<idno type="wicri:Area/Main/Exploration">002559</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Populus balsamifera Extract and Its Active Component Salicortin Reduce Obesity and Attenuate Insulin Resistance in a Diet-Induced Obese Mouse Model.</title>
<author>
<name sortKey="Harbilas, Despina" sort="Harbilas, Despina" uniqKey="Harbilas D" first="Despina" last="Harbilas">Despina Harbilas</name>
<affiliation wicri:level="1">
<nlm:affiliation>Canadian Institutes of Health Research (CIHR) Team in Aboriginal Antidiabetic Medicines, Université de Montréal, P.O. Box 6128, Downtown Station, Montréal, QC, Canada H3C 3J7 ; Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Downtown Station, Montréal, QC, Canada H3C 3J7 ; Institute of Nutrition and Functional Foods, Université Laval, Quebec City, QC, Canada G1V 0A6 ; Montreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada H1W 4A4.</nlm:affiliation>
<country>Canada</country>
<wicri:regionArea>Canadian Institutes of Health Research (CIHR) Team in Aboriginal Antidiabetic Medicines, Université de Montréal, P.O. Box 6128, Downtown Station, Montréal, QC, Canada H3C 3J7 ; Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Downtown Station, Montréal, QC, Canada H3C 3J7 ; Institute of Nutrition and Functional Foods, Université Laval, Quebec City, QC, Canada G1V 0A6 ; Montreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC</wicri:regionArea>
<wicri:noRegion>QC</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Vallerand, Diane" sort="Vallerand, Diane" uniqKey="Vallerand D" first="Diane" last="Vallerand">Diane Vallerand</name>
</author>
<author>
<name sortKey="Brault, Antoine" sort="Brault, Antoine" uniqKey="Brault A" first="Antoine" last="Brault">Antoine Brault</name>
</author>
<author>
<name sortKey="Saleem, Ammar" sort="Saleem, Ammar" uniqKey="Saleem A" first="Ammar" last="Saleem">Ammar Saleem</name>
</author>
<author>
<name sortKey="Arnason, John T" sort="Arnason, John T" uniqKey="Arnason J" first="John T" last="Arnason">John T. Arnason</name>
</author>
<author>
<name sortKey="Musallam, Lina" sort="Musallam, Lina" uniqKey="Musallam L" first="Lina" last="Musallam">Lina Musallam</name>
</author>
<author>
<name sortKey="Haddad, Pierre S" sort="Haddad, Pierre S" uniqKey="Haddad P" first="Pierre S" last="Haddad">Pierre S. Haddad</name>
</author>
</analytic>
<series>
<title level="j">Evidence-based complementary and alternative medicine : eCAM</title>
<idno type="ISSN">1741-427X</idno>
<imprint>
<date when="2013" type="published">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Populus balsamifera L. (BP) is a medicinal plant stemming from the traditional pharmacopoeia of the Cree of Eeyou Istchee (CEI-Northern Quebec). In vitro screening studies revealed that it strongly inhibited adipogenesis in 3T3-L1 adipocytes, suggesting potential antiobesity activity. Salicortin was identified, through bioassay-guided fractionation, as the active component responsible for BP's activity. The present study aimed to assess the potential of BP and salicortin at reducing obesity and features of the metabolic syndrome, in diet-induced obese C57Bl/6 mice. Mice were subjected to high fat diet (HFD) for sixteen weeks, with BP (125 or 250 mg/kg) or salicortin (12.5 mg/kg) introduced in the HFD for the last eight of the sixteen weeks. BP and salicortin effectively reduced whole body and retroperitoneal fat pad weights, as well as hepatic triglyceride accumulation. Glycemia, insulinemia, leptin, and adiponectin levels were also improved. This was accompanied by a small yet significant reduction in food intake in animals treated with BP. BP and salicortin (slightly) also modulated key components in signaling pathways involved with glucose regulation and lipid oxidation in the liver, muscle, and adipose tissue. These results confirm the validity of the CEI pharmacopoeia as alternative and complementary antiobesity and antidiabetic therapies.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
<PMID Version="1">23781256</PMID>
<DateCompleted>
<Year>2013</Year>
<Month>10</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>09</Month>
<Day>29</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Print">1741-427X</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>2013</Volume>
<PubDate>
<Year>2013</Year>
</PubDate>
</JournalIssue>
<Title>Evidence-based complementary and alternative medicine : eCAM</Title>
<ISOAbbreviation>Evid Based Complement Alternat Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Populus balsamifera Extract and Its Active Component Salicortin Reduce Obesity and Attenuate Insulin Resistance in a Diet-Induced Obese Mouse Model.</ArticleTitle>
<Pagination>
<MedlinePgn>172537</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1155/2013/172537</ELocationID>
<Abstract>
<AbstractText>Populus balsamifera L. (BP) is a medicinal plant stemming from the traditional pharmacopoeia of the Cree of Eeyou Istchee (CEI-Northern Quebec). In vitro screening studies revealed that it strongly inhibited adipogenesis in 3T3-L1 adipocytes, suggesting potential antiobesity activity. Salicortin was identified, through bioassay-guided fractionation, as the active component responsible for BP's activity. The present study aimed to assess the potential of BP and salicortin at reducing obesity and features of the metabolic syndrome, in diet-induced obese C57Bl/6 mice. Mice were subjected to high fat diet (HFD) for sixteen weeks, with BP (125 or 250 mg/kg) or salicortin (12.5 mg/kg) introduced in the HFD for the last eight of the sixteen weeks. BP and salicortin effectively reduced whole body and retroperitoneal fat pad weights, as well as hepatic triglyceride accumulation. Glycemia, insulinemia, leptin, and adiponectin levels were also improved. This was accompanied by a small yet significant reduction in food intake in animals treated with BP. BP and salicortin (slightly) also modulated key components in signaling pathways involved with glucose regulation and lipid oxidation in the liver, muscle, and adipose tissue. These results confirm the validity of the CEI pharmacopoeia as alternative and complementary antiobesity and antidiabetic therapies.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Harbilas</LastName>
<ForeName>Despina</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Canadian Institutes of Health Research (CIHR) Team in Aboriginal Antidiabetic Medicines, Université de Montréal, P.O. Box 6128, Downtown Station, Montréal, QC, Canada H3C 3J7 ; Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology, Université de Montréal, P.O. Box 6128, Downtown Station, Montréal, QC, Canada H3C 3J7 ; Institute of Nutrition and Functional Foods, Université Laval, Quebec City, QC, Canada G1V 0A6 ; Montreal Diabetes Research Center, Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada H1W 4A4.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Vallerand</LastName>
<ForeName>Diane</ForeName>
<Initials>D</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Brault</LastName>
<ForeName>Antoine</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Saleem</LastName>
<ForeName>Ammar</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Arnason</LastName>
<ForeName>John T</ForeName>
<Initials>JT</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Musallam</LastName>
<ForeName>Lina</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Haddad</LastName>
<ForeName>Pierre S</ForeName>
<Initials>PS</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2013</Year>
<Month>05</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Evid Based Complement Alternat Med</MedlineTA>
<NlmUniqueID>101215021</NlmUniqueID>
<ISSNLinking>1741-427X</ISSNLinking>
</MedlineJournalInfo>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2013</Year>
<Month>02</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2013</Year>
<Month>04</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2013</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2013</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2013</Year>
<Month>6</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">23781256</ArticleId>
<ArticleId IdType="doi">10.1155/2013/172537</ArticleId>
<ArticleId IdType="pmc">PMC3678421</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Diabetes. 2010 Sep;59(9):2178-87</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20547980</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2002 Jul 12;277(28):25226-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11994296</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Physiol Behav. 2004 Apr;81(2):243-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15159170</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochemistry. 1989 Oct 31;28(22):8683-90</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2481498</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2008 Jan;294(1):E28-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18003720</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Endocrinol Metab. 2008 Nov;93(11 Suppl 1):S64-73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18987272</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2002 Aug 20;99(17):11482-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12177411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 2002 Aug 16;277(33):30153-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12036959</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Med. 2005 Feb;11(2):191-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15685170</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>N Engl J Med. 1996 Feb 1;334(5):292-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8532024</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2001 Aug;108(3):437-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11489937</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1993 Jun 5;268(16):11811-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7685021</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Ethnopharmacol. 2012 Jun 14;141(3):1012-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22504062</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 1999 Aug;48(8):1667-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10426389</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Physiol. 2006 Jul 1;574(Pt 1):7-15</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16644800</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Phytother Res. 2009 Feb;23(2):262-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18844326</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Endocrinol Metab. 2010 Feb;298(2):E141-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20009031</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Trends Cell Biol. 2001 Nov;11(11):437-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11684411</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Ann Hepatol. 2009;8 Suppl 1:S34-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19381122</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2007 Feb;56(2):337-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17259377</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Annu Rev Nutr. 1999;19:379-406</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10448530</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Science. 2001 Aug 31;293(5535):1673-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11533494</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Cell Sci. 2011 May 1;124(Pt 9):1465-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21486951</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Hepatology. 2010 Nov;52(5):1836-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21038418</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nature. 2001 Dec 13;414(6865):799-806</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11742412</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Can J Physiol Pharmacol. 2007 Nov;85(11):1200-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18066122</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Drug Targets. 2011 Jan;12(1):122-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20735354</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Obesity (Silver Spring). 2007 Apr;15(4):798-808</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17426312</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Physiol Res. 2005;54(2):133-40</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15544426</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Inflamm (Lond). 2011 Mar 16;8:8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21410952</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Metabolism. 2001 May;50(5):598-601</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11319724</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Planta Med. 2010 Sep;76(13):1439-46</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20301057</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Obes Metab. 2002 May;4(3):147-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12047393</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes. 2001 Feb;50(2):411-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11272155</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Mol Cell Biol. 2011 Apr;3(2):123-31</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21278199</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Am Acad Nurse Pract. 2002 Apr;14(4):166-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12001747</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Biol Chem. 1957 May;226(1):497-509</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13428781</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mol Membr Biol. 2001 Jul-Sep;18(3):205-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11681787</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Oncogene. 2005 Sep 29;24(43):6465-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16007182</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nutr Res. 2009 Nov;29(11):784-93</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19932867</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Diabetes Metab. 2008 Nov;34(5):439-45</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">18562233</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Exp Ther Oncol. 2006;5(3):195-204</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16528970</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur J Endocrinol. 2003 Mar;148(3):293-300</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12611609</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>IUBMB Life. 2010 May;62(5):315-33</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20209635</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Int J Obes (Lond). 2005 Mar;29 Suppl 1:S13-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15711576</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Biochimie. 2005 Jan;87(1):51-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15733737</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arterioscler Thromb Vasc Biol. 1995 Feb;15(2):269-75</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7538425</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Diab Rep. 2003 Apr;3(2):151-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12728641</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):644-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14715643</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Ethnopharmacol. 2006 Apr 21;105(1-2):55-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">16297584</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Planta Med. 2010 Oct;76(14):1519-24</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20301058</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Clin Nutr. 2009 Mar;89(3):985S-990S</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19176744</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2000 Jul;106(2):171-6</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10903330</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Can J Physiol Pharmacol. 2009 Jun;87(6):479-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19526043</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Arnason, John T" sort="Arnason, John T" uniqKey="Arnason J" first="John T" last="Arnason">John T. Arnason</name>
<name sortKey="Brault, Antoine" sort="Brault, Antoine" uniqKey="Brault A" first="Antoine" last="Brault">Antoine Brault</name>
<name sortKey="Haddad, Pierre S" sort="Haddad, Pierre S" uniqKey="Haddad P" first="Pierre S" last="Haddad">Pierre S. Haddad</name>
<name sortKey="Musallam, Lina" sort="Musallam, Lina" uniqKey="Musallam L" first="Lina" last="Musallam">Lina Musallam</name>
<name sortKey="Saleem, Ammar" sort="Saleem, Ammar" uniqKey="Saleem A" first="Ammar" last="Saleem">Ammar Saleem</name>
<name sortKey="Vallerand, Diane" sort="Vallerand, Diane" uniqKey="Vallerand D" first="Diane" last="Vallerand">Diane Vallerand</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Harbilas, Despina" sort="Harbilas, Despina" uniqKey="Harbilas D" first="Despina" last="Harbilas">Despina Harbilas</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002537 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002537 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    PoplarV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:23781256
   |texte=   Populus balsamifera Extract and Its Active Component Salicortin Reduce Obesity and Attenuate Insulin Resistance in a Diet-Induced Obese Mouse Model.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:23781256" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a PoplarV1 

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Wed Nov 18 12:07:19 2020. Site generation: Wed Nov 18 12:16:31 2020